Preferences for COVID-19 epidemic control measures among French adults: a discrete choice experiment [0.03%]
法国成年人对新冠肺炎疫情防控措施的偏好：一种选择试验的方法
Jonathan Sicsic,Serge Blondel,Sandra Chyderiotis et al.
Jonathan Sicsic et al.
In this stated preferences study, we describe for the first time French citizens' preferences for various epidemic control measures, to inform longer-term strategies and future epidemics. We used a discrete choice experiment in a representa...
Reyes Lorente,Fernando Antonanzas
Reyes Lorente
The attractiveness of jobs in the German care sector: results of a factorial survey [0.03%]
德国护理行业的就业吸引力：因子调查结果
Martin Kroczek,Jochen Späth
Martin Kroczek
The skilled labour shortage in nursing is an issue not unique to Germany. Unattractive characteristics of nursing jobs are one reason for the low supply in nursing personnel. In our study, we analyse the influence of job characteristics on ...
Looking into the black box of "Medical Innovation": rising health expenditures by illness type [0.03%]
透视医疗创新的“黑匣子”：疾病类型与医疗费用上涨的关系分析
Friedrich Breyer,Normann Lorenz,Gerald J Pruckner et al.
Friedrich Breyer et al.
There is agreement among health economists that on the whole medical innovation causes health care expenditures (HCE) to rise. This paper analyzes for which diagnoses HCE per patient have grown significantly faster than average HCE. We dist...
Complexities of health and acceptance of electronic health records for the Austrian elderly population [0.03%]
奥地利老年人群体的健康复杂性及其对电子健康记录的接受度
Nicole Halmdienst,Gerald J Pruckner,Rudolf Winter-Ebmer
Nicole Halmdienst
We examine the personal health situation and how the complexities thereof affect the elderly Austrians' willingness to accept electronic health records (EHR). Using data from the sixth wave of the SHARE survey in Austria, we find the comple...
Mohamad A Khaled,Paul Makdissi,Myra Yazbeck
Mohamad A Khaled
This paper introduces a new graphical tool: the mean deviation concentration curve. Using a unified approach, we derive the associated dominance conditions that identify robust rankings of absolute socioeconomic health inequality for all in...
Inequality, public health, and COVID-19: an analysis of the Spanish case by municipalities [0.03%]
不平等、公共卫生与COVID-19：西班牙各地市的案例分析
Ignacio Amate-Fortes,Almudena Guarnido-Rueda
Ignacio Amate-Fortes
The main objective of this work is to analyze whether inequality in income distribution has an effect on COVID-19 incidence and mortality rates during the first wave of the pandemic, and how the public health system mitigates these effects....
A comprehensive review of official discount rates in guidelines of health economic evaluations over time: the trends and roots [0.03%]
历时全面回顾卫生经济学评价指南中的官方贴现率：趋势与根源
Elahe Khorasani,Majid Davari,Abbas Kebriaeezadeh et al.
Elahe Khorasani et al.
Background: The question of discounting in health economics is anything but settled, so much so that a section of the Health Technology Assessment (HTA) guidelines is devoted to it. ...
Are costs derived from diagnosis-related groups suitable for use in economic evaluations? A comparison across nine European countries in the European Healthcare and Social Cost Database [0.03%]
基于诊断相关的成本数据是否适合用于经济评价？欧洲九个国家的证据
Zuzana Špacírová,David Epstein,Jaime Espín
Zuzana Špacírová
Background: Economic evaluation of health technologies requires healthcare resources, procedures and services to be valued at their opportunity cost. In practice, many economic evaluation studies use official databases of...
The impact of cost-sharing on prescription drug demand: evidence from a double-difference regression kink design [0.03%]
基于双重差分回归拐点设计的成本共担对处方药需求的影响：来自中国的证据
Simona Gamba,Niklas Jakobsson,Mikael Svensson
Simona Gamba
Pharmaceuticals represent the third-largest expenditure item in health care spending in the OECD countries, and cost growth is around 5% per year in many OECD countries. One possible way to contain the rise in pharmaceutical spending is the...